首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Detecting chimerism contributes to diagnosis of graft versus host disease after orthotopic liver transplantation
【24h】

Detecting chimerism contributes to diagnosis of graft versus host disease after orthotopic liver transplantation

机译:检测嵌合体有助于诊断原位肝移植后移植物抗宿主疾病

获取原文
获取原文并翻译 | 示例
       

摘要

To the Editor:Graft versus host disease(GVHD)occurs when the immunocompetent cells from the donor mount an immune response against the tissues of the host[1].It is commonly seen in the patients who received hematopoietic stem cell transplantation(HSCT).GVHD is a rare but lethal complication in orthotopic liver transplantation(OLT).The incidence varies from 0.1%to 2.0%,while the mortality rate is up to 75.0%[2–4].Herein,we reported a successfully treated case of GVHD after OLT,who was diagnosed timely with the help of a novel chimerism test technique,and was treated with drug withdraw and basiliximab.The patient,male,65-year-old,was in poor nutrition with the body mass index(BMI)of 20.7 kg/m^2.He had a long history of hepatitis B virus(HBV)infection,and was diagnosed with hepatocellular carcinoma(single focus with the diameter of 4.3 cm,no distant metastasis,within the Milan Criteria)for three months.

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2018年第004期|363-366|共4页
  • 作者单位

    Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha 410013, China;

    Engineering Technology Research Center for TransplantationMedicine of National Ministry of Health, Changsha 410013, China;

    Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha 410013, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:12
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号